Feature Products

featured product

Investor Relations

1HFY2013 FINANCIAL HIGHLIGHTS (FOR HALF YEAR ENDED 31 DECEMBER 2012)

 

Group

 

1.7.2012 to 31.12.2012

1.7.2011 to 31.12.2011

Change

1.10.2012 to 31.12.2012

1.10.2011 to 31.12.2011

Change

 

RMB '000

RMB '000

%

RMB '000

RMB '000

%

Revenue

1,474,311

1,012,167

45.7%

860,900

650,787

32.3%

Cost of sales

(974,036)

(626,997)

55.3%

(546,496)

(412,616)

32.4%

Gross profit

500,275

385,170

29.9%

314,404

238,171

32.0%

Gross profit margin (%)

33.9%

38.1%

(4.2ppt)

36.5%

36.6%

(0.1ppt)

Loss on fair value of biological assets less estimated point of sales cost

(9,000)

(4,400)

(104.5%)

(9,000)

(4,400)

(104.5%)

Other income, net

10,826

12,565

(13.8%)

5,575

6,018

(7.4%)

Selling and distribution
expenses                        

(60,683)

(40,415)

50.1%

(35,747)

(19,876)

79.9%

Administrative expenses

(49,382)

(49,044)

0.7%

((27,908)

(26,061)

7.1%

Other expenses, net

(5,177)

(1,761)

37.6%

(4,359)

(901)

383.8%

Financial expenses, net

(26,483)

(14,187)

86.7%

(18,821)

(8,618)

118.4%

Profit before income tax

360,376

287,928

25.2%

224,144

184,333

21.6%

Income tax expense

(22,950)

(20,116)

14.1%

(8,330)

(9,663)

(13.8%)

Profit for the period

337,426

267,812

26.0%

215,814

174,670

23.6%

Net Profit margin (%)

22.9%

26.5%

(3.6ppt)

25.1%

26.8%

(1.7ppt)

Currency translation difference arising from consolidation

856

(2,135)

140.1%

(4)

(376)

(98.9%)

Total comprehensive income

338,282

265,6773

27.3%

215,810

174,294

23.8%

Earnings per share (RMB)

Basic

0.61

0.48

27.1%

0.39

0.31

25.8%

Diluted

0.61

0.48

27.1%

0.39

0.31

25.8%